알림
뒤로

Invisible becomes undeniable.

Preclinical & translational imaging CRO for human-relevant insights.

50+ 

Biotech
Collaborations

80+ 

Drug

Pipelines

200+ 

Projects

Successfully

Delivered

We use molecular imaging to visualize, quantify, and characterize biological processes happening in real time—at the cellular and molecular levels—within living systems. 


This accelerates drug development by up to 5x.

By shed a "light"

Radio-labeling

To visualize and quantify the characteristics of various modalities

Radio-labeled Antibody
Radio-labeled Antibody
Radio-labeled Vesicle
Radio-labeled Vesicle

We provides 
molecular imaging services

Antibody PK Imaging

At molim Inc., we harness the power of nuclear medicine and molecular imaging to pioneer advancements in antibody therapeutics. By labeling antibodies with radioactive isotopes, we provide crucial insights into their biodistribution, targeting capabilities, and clearance from the body.


Visualize Antibody Binding
Monitor Therapeutic Responses
Optimize Dosage and Timing

EV PK Imaging

molim Inc. is at the forefront of exploring the role of extracellular vesicles (EVs) in therapeutic delivery and disease pathogenesis using state-of-the-art molecular imaging techniques. 


Track EV Distribution
Understand EV Cargo Delivery
Evaluate EV Dynamics

Visualizing and quantifying how drug candidates behave — across tissues, cells, and molecules. 


더보기

Have a question?

We're happy to help.

--
Send

Regulatory Science

Our data and documentation prioritize Regulatory Science.

Investigational New Drug (IND) Application · New Drug Application (NDA) · Electronic Common Technical Document ((e)CTD) · Clinical Data Interchange Standards Consortium (CDISC) · (Non-)Clinical Trial Statistical Analysis

High Quality

Establishing Quality for Non-Clinical and Clinical Investigational Drugs


We ensure the highest quality of non-clinical investigational drugs through:


  • Analytical studies to demonstrate the surrogacy of drug candidates labeled with radioisotopes and fluorescent/luminescent dyes. This means we verify that the labeled drug behaves in the same way as the unlabeled drug.
  • Quality assessment of drug candidates labeled with radioisotopes and fluorescent/luminescent dyes. We rigorously evaluate the purity, stability, and other critical quality attributes of these specialized compounds.
  • Evaluation of chemical and biological properties of non-clinical investigational drugs using in vitro and ex vivo cell and tissue samples. We conduct comprehensive analyses to characterize the drug's interaction with biological systems outside of a living organism.1

Study Management Standards


  • Standard Operating Procedure (SOP) Implementation

  • IACUC/IRB Oversight (Institutional Animal Care and Use Committee / Institutional Review Board)

  • Research Notebook Documentation

  • Quality Assurance (QA) Activities

  • Facility, Equipment, and Instrument Validation

  • Analytical Method Validation

Contact Us


🗺️ Address: Building "B" 4F, 145, Gwanggyo-ro, Yeongtong-gu, Sowon, Gyeonggi-do, Republic of Korea

📞 Telephone: +82-31-711-2806

✉️ Email: contact@molim.xyz

Follow us